Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematological Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT05038384
What this trial is testing

Palliative, Rehabilitation, and Integrated Medicine Handbook for Self Care at Work

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
M.D. Anderson Cancer Center
Not applicableLooking for participantsNCT05556928
What this trial is testing

Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry

Who this might be right for
Multiple MyelomaAmyloidosisPlasma Cell Leukemia
University of Alabama at Birmingham 5,000
Early research (Phase 1)Ended earlyNCT00649584
What this trial is testing

A Phase I Dose Escalation Study of SGN-35 Alone and in Combination With Gemcitabine for CD30-Positive Malignancies

Who this might be right for
Disease, HodgkinLymphoma, Large-Cell, AnaplasticLymphoma, Non-Hodgkin
Seagen Inc. 44
Large-scale testing (Phase 3)Looking for participantsNCT06378138
What this trial is testing

ICP-248 in Combination With Orelabrutinib in Treatment-naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (APEX-03)

Who this might be right for
Hematologic Malignancies
Beijing InnoCare Pharma Tech Co., Ltd. 226
Not applicableStudy completedNCT01726699
What this trial is testing

Scripps Tumorgraft Study

Who this might be right for
Solid Tumor Malignancy or Hematologic Malignancy
Scripps Translational Science Institute 11
Not applicableStudy completedNCT03654404
What this trial is testing

A Proof-of-Concept Trial of a Positive Psychology Intervention for Allogeneic Stem Cell Transplant Patients

Who this might be right for
Hematologic MalignancyHematopoietic/Lymphoid CancerBlood Cancer
Brigham and Women's Hospital 29
Not applicableLooking for participantsNCT05708716
What this trial is testing

Diet and Cognitive Training in Hematologic Cancer Survivors

Who this might be right for
Cognitive ImpairmentHematologic Malignancy
University of Alabama at Birmingham 80
Not applicableLooking for participantsNCT07357038
What this trial is testing

A Real-world Prospective Observational Study on the Efficacy and Safety of L-AmB(Liposomal Amphotericin B) for br- IFD(Breakthrough Invasive Fungal Disease) in Children and Adolescent Patients With Hematological Malignancies Receiving Triazoles or Echinocandins Prophylaxis

Who this might be right for
Fungal Disease
Institute of Hematology & Blood Diseases Hospital, China 38
Early research (Phase 1)Not Yet RecruitingNCT06528249
What this trial is testing

Safety, Tolerability and Preliminary Efficacy of Erythrocyte-αPD-1 Conjugate in Patients With Advanced Malignancies

Who this might be right for
CancerSolid TumorHematologic Malignancy
Zhejiang Provincial People's Hospital 39
Not applicableStudy completedNCT04788758
What this trial is testing

Geriatric Assessment Screening Tool for the Identification of At-Risk Older Adults Who Are Undergoing Cancer Treatment

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
Thomas Jefferson University 76
Early research (Phase 1)Not Yet RecruitingNCT07110194
What this trial is testing

Phase I Clinical Trial of TQB2825 Subcutaneous Injection in CD20-positive Hematological Malignancies

Who this might be right for
CD20-positive Hematological Malignancies
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. 75
Not applicableUnknownNCT02828462
What this trial is testing

Impact of a Monitoring Device for Patients With Cancer Treated Using Oral Therapeutics

Who this might be right for
Metastatic CancerHematological Malignancy
Gustave Roussy, Cancer Campus, Grand Paris 1,000
Post-approval studies (Phase 4)Active Not RecruitingNCT04296305
What this trial is testing

Effect of Opioid Infusion Rate on Abuse Liability Potential of Intravenous Hydromorphone for Cancer Pain

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
M.D. Anderson Cancer Center 84
Early research (Phase 1)Not Yet RecruitingNCT06647329
What this trial is testing

CAR-T Technology for Recurrent/Refractory Malignant Hematological and Lymphatic Tumors

Who this might be right for
CAR-T Cell TherapyLymphomas
Mingzhi Zhang 30
Testing effectiveness (Phase 2)Study completedNCT00005942
What this trial is testing

Liposomal Daunorubicin and SU5416 in Treating Patients With Hematologic Cancer That Has Not Responded to Initial Therapy

Who this might be right for
Chronic Myelomonocytic LeukemiaPreviously Treated Myelodysplastic SyndromesRecurrent Adult Acute Myeloid Leukemia+2 more
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Study completedNCT02743351
What this trial is testing

Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies

Who this might be right for
Hematologic MalignanciesAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+3 more
Fate Therapeutics 96
Testing effectiveness (Phase 2)Ended earlyNCT01500161
What this trial is testing

Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Lymphocytic Leukemia+6 more
Texas Oncology Cancer Center 1
Not applicableStudy completedNCT03349931
What this trial is testing

Prospective Multicenter Evaluation of the MycoGenie Kit for the Diagnosis of Invasive Aspergillosis

Who this might be right for
Invasive Aspergillosis in Patients With Onco-haematological Diseases
Assistance Publique - Hôpitaux de Paris 350
Early research (Phase 1)Study completedNCT02492737
What this trial is testing

Study of Orally Administered AG-881 in Patients With Advanced Hematologic Malignancies With an IDH1 and/or IDH2 Mutation

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic SyndromeHematologic Malignancies
Agios Pharmaceuticals, Inc. 46
Very early researchStudy completedNCT05902845
What this trial is testing

RD13-02 CAR-T Cell Injection for Patients With r/r CD7+ T-ALL/T-LBL

Who this might be right for
NeoplasmsHematologic NeoplasmsHematologic Diseases
Xiaoyu Zhu 4
Next Page